IL148752A0 - Granules based on starch and lactose - Google Patents

Granules based on starch and lactose

Info

Publication number
IL148752A0
IL148752A0 IL14875201A IL14875201A IL148752A0 IL 148752 A0 IL148752 A0 IL 148752A0 IL 14875201 A IL14875201 A IL 14875201A IL 14875201 A IL14875201 A IL 14875201A IL 148752 A0 IL148752 A0 IL 148752A0
Authority
IL
Israel
Prior art keywords
starch
lactose
granules based
granules
test
Prior art date
Application number
IL14875201A
Other languages
English (en)
Original Assignee
Roquette Freres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres filed Critical Roquette Freres
Publication of IL148752A0 publication Critical patent/IL148752A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated
IL14875201A 2000-07-27 2001-07-25 Granules based on starch and lactose IL148752A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00402159A EP1175899B1 (de) 2000-07-27 2000-07-27 Granulat bestehend aus Stärke und Laktose
PCT/FR2001/002432 WO2002009673A1 (fr) 2000-07-27 2001-07-25 Granules a base d'amidon et de lactose

Publications (1)

Publication Number Publication Date
IL148752A0 true IL148752A0 (en) 2002-09-12

Family

ID=8173789

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14875201A IL148752A0 (en) 2000-07-27 2001-07-25 Granules based on starch and lactose

Country Status (23)

Country Link
US (1) US6770368B2 (de)
EP (1) EP1175899B1 (de)
JP (1) JP4394313B2 (de)
KR (1) KR100869171B1 (de)
CN (1) CN1253148C (de)
AT (1) ATE371439T1 (de)
AU (1) AU785135B2 (de)
BR (1) BR0107036A (de)
CA (1) CA2353363C (de)
CZ (1) CZ303682B6 (de)
DE (1) DE60036205T2 (de)
ES (1) ES2292414T3 (de)
HU (1) HU229277B1 (de)
IL (1) IL148752A0 (de)
MX (1) MXPA01007666A (de)
NO (1) NO333750B1 (de)
NZ (1) NZ517931A (de)
PL (1) PL203778B1 (de)
RS (1) RS49931B (de)
RU (1) RU2286142C2 (de)
SK (1) SK286951B6 (de)
WO (1) WO2002009673A1 (de)
ZA (1) ZA200202178B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826549A1 (fr) * 2001-06-28 2003-01-03 Roquette Freres Procede de preparation d'un comprime edulcorant et comprime edulcorant ainsi obtenu.
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible
FR2834894B1 (fr) * 2002-01-21 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de piribedil
FR2834891B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de 2-({2-methoxy-2-[3(trifluoromethyl)phenyl]ethyl}amino)ethyl4 -(2-(9h-fluoren-9-yl)acetyl]amino}ethyl)benzoate
FR2834896B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'ivabradine
FR2834897B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de testosterone
FR2834892B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de mitiglinide
FR2834893B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de perindopril
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
US20030228370A1 (en) * 2002-06-11 2003-12-11 Michel Serpelloni Orodispersible solid pharmaceutical form
FR2857593B1 (fr) * 2003-07-18 2005-10-14 Servier Lab Composition pharmaceutique orodispersible d'un compose antithrombotique
GB0329208D0 (en) * 2003-12-17 2004-01-21 Ici Plc Particulate materials
GB0523810D0 (en) * 2005-11-23 2006-01-04 Astrazeneca Ab Pharmaceutical compositions
FR2894475B1 (fr) * 2005-12-14 2008-05-16 Servier Lab Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine
EP2100610A4 (de) * 2006-12-07 2009-12-02 Daiichi Sankyo Co Ltd Pharmazeutische zusammensetzung mit niedrig substituierter hydroxypropylcellulose
TWI428151B (zh) * 2006-12-07 2014-03-01 Daiichi Sankyo Co Ltd 含有甘露醇或乳糖之固形製劑
TWI442947B (zh) * 2006-12-07 2014-07-01 Daiichi Sankyo Co Ltd 安定性經改善之薄膜塗覆製劑
WO2008072532A1 (ja) * 2006-12-07 2008-06-19 Daiichi Sankyo Company, Limited 貯蔵安定性が改善された医薬組成物
FR2933299B1 (fr) 2008-07-04 2012-02-03 Roquette Freres Mannitol orodispersible
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis
WO2010092828A1 (ja) * 2009-02-12 2010-08-19 富士化学工業株式会社 崩壊性粒子組成物及びそれを用いた速崩壊性圧縮成型物
FR2944971B1 (fr) * 2009-04-30 2012-09-07 Roquette Freres Coagglomerats de mannitol et d'amidon granulaire comprimables et a ecoulement libre
RU2013102893A (ru) * 2010-06-23 2014-07-27 Колгейт-Палмолив Компани Инкапсуляция ингредиентов в лактозной матрице для получения активных инкапсулятов
FR2966828B1 (fr) 2010-11-02 2012-12-28 Roquette Freres Poudre de polysaccharide et de polyol, comprimable et de haute viscosite
JP5483482B2 (ja) * 2011-05-23 2014-05-07 三井製糖株式会社 糖液から固形物を製造する方法及び固形物
CN102516321A (zh) * 2011-12-08 2012-06-27 上海天伟生物制药有限公司 一种药用乳糖及其制备方法和用途
JP5276199B1 (ja) * 2012-03-23 2013-08-28 池田食研株式会社 多孔質顆粒の製造方法
US9522964B2 (en) * 2012-04-03 2016-12-20 Development, Inc. Micronized starch and methods for manufacturing same
CA2955845C (en) * 2014-07-21 2022-08-16 Roquette Freres Sugar compositions for tableting by direct compression
EP3002005A1 (de) 2014-09-30 2016-04-06 Molkerei Meggle Wasserburg GmbH & Co. Kg Direktkomprimierter Hilfsstoff auf Basis von Lactose, Cellulose und Stärke
EP3034070A1 (de) * 2014-12-18 2016-06-22 Omya International AG Verfahren zur Herstellung eines pharmazeutischen Abgabesystems
JP6544564B2 (ja) * 2015-04-20 2019-07-17 清水建設株式会社 模擬粉体、及び粉体飛散状態評価方法
US10820608B1 (en) 2015-10-26 2020-11-03 The Hershey Company Hard candy confections with low hygroscopicity
CN110248926B (zh) * 2017-01-24 2022-12-06 石药集团中奇制药技术（石家庄）有限公司 Lsd1抑制剂及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE575343A (de) * 1955-09-09
AT376147B (de) * 1980-12-15 1984-10-10 Gergely Gerhard Verfahren und vorrichtung zum granulieren eines pulvergemisches
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
US5043170A (en) * 1989-02-14 1991-08-27 Hoffmann-La Roche Inc. Animal feed composition containing a vitamin D metabolite
JPH0584054A (ja) * 1991-09-27 1993-04-06 Kunoole Shokuhin Kk スープまたはソース粉末もしくは顆粒の製造法
JP3349535B2 (ja) * 1993-01-12 2002-11-25 フロイント産業株式会社 球形顆粒の製造方法
JPH08298956A (ja) * 1995-05-10 1996-11-19 Ajinomoto Co Inc 顆粒状調味料の製造方法
JPH0937737A (ja) * 1995-05-25 1997-02-10 Tokiwa Kanpo Seiyaku:Kk 菊花含有健康食品
JP3611652B2 (ja) * 1995-10-30 2005-01-19 長谷川香料株式会社 コーティング粉末の製造方法
DE19603984A1 (de) * 1996-02-05 1997-08-07 Bayer Ag Granulate von Triazinen
JP3934179B2 (ja) * 1996-07-11 2007-06-20 不二製油株式会社 動物の体内へ摂取される物質からなる粉体を造粒する方法及び造粒物
JP3447042B2 (ja) * 1997-07-23 2003-09-16 フロイント産業株式会社 単一物質球形粒の製造方法

Also Published As

Publication number Publication date
ATE371439T1 (de) 2007-09-15
NO20021424D0 (no) 2002-03-21
RS49931B (sr) 2008-09-29
US6770368B2 (en) 2004-08-03
EP1175899A1 (de) 2002-01-30
RU2286142C2 (ru) 2006-10-27
US20020035248A1 (en) 2002-03-21
DE60036205T2 (de) 2008-05-21
JP2002142690A (ja) 2002-05-21
PL203778B1 (pl) 2009-11-30
KR20020063868A (ko) 2002-08-05
MXPA01007666A (es) 2004-08-11
AU785135B2 (en) 2006-10-05
NO333750B1 (no) 2013-09-09
CA2353363C (fr) 2010-06-01
CA2353363A1 (fr) 2002-01-27
AU7990901A (en) 2002-02-13
CN1386064A (zh) 2002-12-18
SK3702002A3 (en) 2002-08-06
NO20021424L (no) 2002-03-21
SK286951B6 (sk) 2009-08-06
PL353056A1 (en) 2003-10-06
WO2002009673A1 (fr) 2002-02-07
CZ303682B6 (cs) 2013-03-06
NZ517931A (en) 2003-11-28
CZ2002978A3 (cs) 2002-06-12
YU22002A (sh) 2004-09-03
BR0107036A (pt) 2002-06-04
CN1253148C (zh) 2006-04-26
DE60036205D1 (de) 2007-10-11
RU2002111360A (ru) 2004-01-10
HU229277B1 (en) 2013-10-28
JP4394313B2 (ja) 2010-01-06
KR100869171B1 (ko) 2008-11-19
ZA200202178B (en) 2003-06-05
EP1175899B1 (de) 2007-08-29
HUP0203064A2 (en) 2003-03-28
ES2292414T3 (es) 2008-03-16

Similar Documents

Publication Publication Date Title
ZA200202178B (en) Granules based on starch and lactose.
AP9901534A0 (en) Pharmaceutical formulations.
CA2137203A1 (en) Protein kinase c inhibitors
CA2348086A1 (en) Controlled-release pharmaceutical formulations
BG103930A (en) Eletriptan hemisulphate and caffeine containing pharmaceutical compositions
ATE317845T1 (de) Pharmazeutische zusammensetzung, enthaltend 2,3- diaryl-pyrazolo(1,5-b)pyridazin derivate
WO2002047671A3 (en) Lactam compound to inhibit beta-amyloid peptide release or synthesis
TR200001603T2 (tr) Yeni bileşikler
HK1046403A1 (en) Nematicidal trifluorobutenes.
ATE215954T1 (de) Pyrazolo(4,3-d)pyrimidin-derivate und diese enthaltende pharmazeutische zubereitungen
MXPA03002911A (es) Compuestos quimicos.
IL127918A0 (en) Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations
IL129176A0 (en) Compressed lozenge containing 1,1-GPS (1-O-alpha-D-glucopyranosyl-D-sorbitol)
NO20012249D0 (no) Faststoffsammensetning inneholdende D-mannitol og cerivastatin samt anvendelse av faststoffsammensetning forfremstilling av farmasöytisk preparat
EP0298666A3 (en) Spray dried ibuprofen compositions
IL132599A0 (en) Substituted 3,3-diamino-2-propenenitriles their preparation and use
CA2284142A1 (en) Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
AP2001002369A0 (en) Pharmaceutical complex.
DK0835656T3 (da) Kombinationspræparat indeholdende tramadol og en calciumkanalantagonist
FI923751A0 (fi) Hexahydrobenso/f/kinolinoner.
AU4450489A (en) The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c
AU6601000A (en) 3-oxopropane-1-sulphonic acids and sulphonates
WO2001071346A3 (en) Binding compounds for cc chemokine receptor 5 and methods for identifying them
EP0316639A3 (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
MXPA04005226A (es) 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion.

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed